| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/08/2010 | CA2738993A1 Pharmaceutical composition utilising combinations of variants of the gonadotropin-releasing hormone (gnrh) as immunogen |
| 04/08/2010 | CA2738912A1 Pharmaceutical composition for oral administration |
| 04/08/2010 | CA2737395A1 New controlled release active agent carrier |
| 04/08/2010 | CA2737263A1 Mucomimetic compositions and uses therefore |
| 04/08/2010 | CA2732613A1 Oral formulation |
| 04/08/2010 | CA2730261A1 Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof |
| 04/07/2010 | EP2172225A1 Sealmess capsule |
| 04/07/2010 | EP2172224A1 Aqueous composition |
| 04/07/2010 | EP2172216A2 Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
| 04/07/2010 | EP2172205A1 Pharmaceutical Formulation Comprising Lanthanum Compounds |
| 04/07/2010 | EP2172202A1 Prostaglandin derivative-containing aqueous liquid agent |
| 04/07/2010 | EP2172200A1 Coated preparation |
| 04/07/2010 | EP2172199A1 Sustained release tablet comprising pramipexole |
| 04/07/2010 | EP2172196A1 Composition containing coenzyme q10 |
| 04/07/2010 | EP2172192A1 Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder of granular material, and process and tooling for producing it |
| 04/07/2010 | EP2172189A1 Pharmaceutical Compositions |
| 04/07/2010 | EP2172106A1 Allantoin-containing skin cream |
| 04/07/2010 | EP2171095A1 Mixed micelles including amphipathic conjugates of rna agents, and uses thereof |
| 04/07/2010 | EP2170930A2 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| 04/07/2010 | EP2170401A1 Dendrimer conjugates of agonists and antagonists of the gpcr superfamily |
| 04/07/2010 | EP2170400A1 Pharmaceutical liquid composition of botulinum toxin with improved stability |
| 04/07/2010 | EP2170399A1 Intranasal administration of asenapine and pharmaceutical compositions therefor |
| 04/07/2010 | EP2170370A2 Recombinant transferrin mutants |
| 04/07/2010 | EP2170368A1 Liquid protein formulations comprising gdf-5 for use at elevated temperatures |
| 04/07/2010 | EP2170332A1 A medicament for treating glaucoma comprising as an active ingredient cyclodextrin-clathrate compound of cilostazol |
| 04/07/2010 | EP2170313A2 Aqueous formulations of acetaminophen for injection |
| 04/07/2010 | EP2170310A2 Quick dissolve compositions of memantine hydrochloride |
| 04/07/2010 | EP2170302A1 Sustained release bionanocomposites, a process for producing the same and use thereof |
| 04/07/2010 | EP2170290A1 System for controlled release of an active principle and method for preparation |
| 04/07/2010 | EP2170279A1 Methods for producing aripiprazole suspension and freeze-dried formulation |
| 04/07/2010 | EP2170270A2 Compositions for delivering medicaments into the lungs, uses thereof |
| 04/07/2010 | EP2170268A2 Compositions of specific binding agents to hepatocyte growth factor |
| 04/07/2010 | EP2170267A1 Cationic peptide for delivering an agent into a cell |
| 04/07/2010 | EP2170054A2 Targeting conjugates comprising active agents encapsulated in cyclodextrin-containing polymers |
| 04/07/2010 | EP1583559B1 Compositions for prevention and treatment of cold and influenza-like symptoms comprising select mucoadhesive polymers |
| 04/07/2010 | EP1423150B1 Sustained release of microcrystalline peptide suspensions |
| 04/07/2010 | EP1254237B1 Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates |
| 04/07/2010 | EP1208005B1 Temperature-sensitive polymer/nanoshell composites for photothermally modulated drug delivery |
| 04/07/2010 | EP1121155B1 Site-directed dual pegylation of proteins |
| 04/07/2010 | CN1985967B Medicine for treating chronic bronchitis and bronchial asthma and its preparing method |
| 04/07/2010 | CN1578647B Implantable and sealable system for unidirectional delivery of therapeutic agents to tissues |
| 04/07/2010 | CN101690823A Method for preparing RGDV-containing cytosine arabinoside conjugate pharmacosome and application as antitumor agent |
| 04/07/2010 | CN101690822A Medicament carrier for targeted medicament delivery on diseases related to macrophage and preparation method thereof |
| 04/07/2010 | CN101690821A Immune protective agent of attenuated living vaccine against infectious bursal disease and preparation method thereof |
| 04/07/2010 | CN101690820A Nano microsphere loading with platinum-containing drugs, hydrogel coated with natural polymers and preparation method and application thereof |
| 04/07/2010 | CN101690819A Chitosan nano-particle with photo-sensitive characteristic and preparation method thereof |
| 04/07/2010 | CN101690818A Cataplasm matrix and preparation method thereof |
| 04/07/2010 | CN101690817A Method for chemically grafting and modifying titanium dioxide nano-tubes through polyethylene glycol |
| 04/07/2010 | CN101690809A Propolis-astragalus polysaccharides compound nanometer emulsion adjuvant and preparation method and application thereof |
| 04/07/2010 | CN101690806A schistosomiasis japonica arborization carrier-DNA vaccine and preparation method thereof |
| 04/07/2010 | CN101690804A Medicinal preparations for treating cerebral diseases by transtympanic administration |
| 04/07/2010 | CN101690803A Medicinal preparations for treating inner ear diseases by transtympanic administration |
| 04/07/2010 | CN101690802A Cervical mucosa inducing gel |
| 04/07/2010 | CN101690777A Formula of polygonatum chewable tablets and preparation method thereof |
| 04/07/2010 | CN101690734A Lactobacillus vaginal capsule and preparation method thereof |
| 04/07/2010 | CN101690724A Piperazine ferulate enteric preparation and preparation method thereof |
| 04/07/2010 | CN101690720A Carteolol orally disintegrating tablets and preparation method thereof |
| 04/07/2010 | CN101690719A Bisulfate clopidogrel solid preparation, particles and preparation method thereof |
| 04/07/2010 | CN101690718A Carteolol hydrochloride pellets, preparation method thereof and preparation thereof |
| 04/07/2010 | CN101690717A Valnemulin for livestock and saline premix and preparation method thereof |
| 04/07/2010 | CN101690716A Calcium alginate-chitosan sustained-release microsphere carrying growth hormone and application thereof |
| 04/07/2010 | CN101690715A Method for preparing immunoglobulin G liposome by using milk fat globule membrane phospholipids |
| 04/07/2010 | CN101690714A Antimicrobial, antiprotozoal and antitumor allicin liposome and preparation method thereof |
| 04/07/2010 | CN101690712A Sitafloxacin eye drop and preparation method thereof |
| 04/07/2010 | CN101690711A Substrate of pain-relieving plaster for injury and rheumatism and preparation method thereof |
| 04/07/2010 | CN101690573A Production method of fructus monordicae extract with over 60% of mogroside V content |
| 04/07/2010 | CN101148483B Chitosan oligosaccharide-stearic acid grafting compound modified by folic acid, preparation method and application thereof |
| 04/07/2010 | CN101077417B Magnetic target medicine sustained and controlled release carrier material and preparation method and application thereof |
| 04/07/2010 | CN101045033B Ply-glycosyl modified acid-sensitive nanometer gel |
| 04/07/2010 | CN101032473B Sandwich type medical releasing film and preparing method thereof |
| 04/07/2010 | CN101015698B Medicament using rare earth transferring complex compound as vector |
| 04/06/2010 | US7692002 to coordinate vitamin B12 through its cyanide to a metal to form a [Co]-CN-M complex, wherein [Co] represents vitamin B12 without cyanide; such vitamin B12 derivatives are chemically stable and can be easily produced; e.g. use of precursor complex cis-diamminedichloroplatinum(II) |
| 04/06/2010 | US7691975 Interferon-β complex |
| 04/06/2010 | US7691963 or exendin-4 agonists covalently bonded to albumin, polyethylene glycol, gelatin, (hydroxypropyl)-methacrylamide, a polyamino acid, fatty acid, polysaccharide, dextran to increase molecular size; diabetes, postprandial dumping syndrome, postprandial hyperglycemia, dyslipidemia, obesity; renal filtration |
| 04/06/2010 | US7691906 comprises fatty acids; for treatment/prevention of sepsis or inflammatory shock |
| 04/06/2010 | US7691903 Oxidation-sensitive hydrophilic active principle containing composition and use thereof |
| 04/06/2010 | US7691897 Therapeutic agent |
| 04/06/2010 | US7691871 Multivitamin syrup for children or young adults |
| 04/06/2010 | US7691826 Polysialic acid derivatives |
| 04/06/2010 | US7691806 Mixture of protein polymer and active materials |
| 04/06/2010 | US7691627 Nucleic acid sequences encoding D1 and D1/D2 domains of human coxsackievirus and adenovirus receptor (CAR) |
| 04/06/2010 | US7691603 Intracellular formation of peptide conjugates |
| 04/06/2010 | US7691412 dissolving active principle in water; emulsifying resulting solution of active principle with d,l-lactide-co-glycolide matrix copolymer, emulsifying first emulsion in external aqueous phase containing surfactant, viscosity-enhancing agent, osmotic agent, extraction-evaporation to form microspheres |
| 04/06/2010 | US7691411 Pharmaceutical formulae for thyroid hormones and procedures for obtaining them |
| 04/06/2010 | US7691408 Composition having gelling properties for the prolonged delivery of bioactive substances |
| 04/06/2010 | US7691404 Acrylate adhesive, a polyvinylpyrrolidone having a molecular weight of 1,000,000-5,000,000; a polyvinylpyrrolidone having a molecular weight of 2,000-50,000; a non-ionic surfactant; a terpene; and a dissolution assistant. |
| 04/06/2010 | US7691380 Coagulating the vascular systems of cancer cells through site specific delivery of coagulant antibodies causing regression of the cells |
| 04/06/2010 | US7691379 Anti-IL-9 antibody formulations |
| 04/06/2010 | US7691367 A therapeutic polypeptide drug conjugated with two chains of polyoxyethylene glycol, linked to a cyclohexane ring; high molecular weight, stability, nontoxic, sustained release |
| 04/06/2010 | US7691285 Magnetic nanoparticles having improved magnetic properties |
| 04/06/2010 | CA2468801C Hydroxycucurbituril derivatives, their preparation methods and uses |
| 04/06/2010 | CA2453507C A controlled release biodegradable gel matrix |
| 04/06/2010 | CA2451379C Oral pharmaceutical compositions with modified release of the active ingredient |
| 04/06/2010 | CA2406807C Methods and compositions for the prevention and treatment of anemia |
| 04/06/2010 | CA2386017C Drug delivery of phase changing formulation |
| 04/06/2010 | CA2375361C An antimicrobial composition |
| 04/06/2010 | CA2358505C Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules |
| 04/06/2010 | CA2331274C Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof |
| 04/06/2010 | CA2253243C Antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis |
| 04/02/2010 | CA2678320A1 Transdermal drug delivery system for liquid active ingredient |